Statement of Charles N. Oster, M.D.

At the conclusion of our discussion, I took COL Dangerfield to
Ward 11 and introduced him to Dr. Jeff Lennox, the new director of
Clinical Research and the study nurses. Dr. Nzera Verani ran the
vaccine studies until she resigned in August 91; following that the
M.D.'s in LTC Redfield's laboratory took turns coming here to
perform doctor functions on study patients. As a result of this,
I went out of the loop. Dr. Lennox came in July 1992 to be in
charge of HIV clinical research. During the visit, COL Dangerfield
was told that none of the 30 patients in the Phase I original study
were receiving AZT but in the rollover phase six or seven had been
placed on AZT because of medical indications.
3